Systemic Lupus Erythematosus, Congenital Heart Block and Neonatal Lupus
Author:
Chang Christopher
Publisher
Springer New York
Reference21 articles.
1. Abrahams VM, Borghi MO, et al. What is the mechanism(s) of antiphospholipid antibody-mediated pregnancy morbidity? In: Erkan D, Pierangeli SS, editors. Antiphospholipid syndrome: insights and highlights from the 13th international congress on antiphospholipid antibodies. New York: Springer; 2012. p. 79–101.
2. Boutjdir M. Molecular and ionic basis of congenital complete heart block. Trends Cardiovasc Med. 2000;10(3):114–22.
3. Buyon JP, Hiebert R, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31(7):1658–66.
4. Capone C, Buyon JP, et al. Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population. Cardiol Rev. 2012;20(2):72–6.
5. Chang C. Neonatal autoimmune diseases. Lupus. 2012;21:1487–91.